Hizentra 20% subcutaneous injection 1g/5mL (YJ code: 6343439A1024, 1g 5mL 1 bottle), manufactured by CSL Behring, contains pH4 treated acidic human immunoglobulin (subcutaneous injection). Hizentra is used as replacement therapy for primary immunodeficiency (PI) and for maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP).
Hizentra 20% subcutaneous injection 1g/5mL
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).